Voloridge Investment Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-69,114
Closed -$259K 1335
2024
Q1
$259K Buy
+69,114
New +$405K ﹤0.01% 1093
2023
Q4
Sell
-386,690
Closed -$3.23M 1391
2023
Q3
$3.23M Sell
386,690
-563,774
-59% -$6.44M 0.02% 788
2023
Q2
$12.6M Sell
950,464
-764,942
-45% -$9.3M 0.06% 402
2023
Q1
$19.9M Buy
1,715,406
+1,523,472
+794% +$15.1M 0.1% 281
2022
Q4
$1.57M Buy
+191,934
New +$1.65M 0.01% 1033
2022
Q3
Sell
-220,926
Closed -$976K 1570
2022
Q2
$976K Sell
220,926
-625,254
-74% -$3.8M 0.01% 1197
2022
Q1
$7.7M Buy
+846,180
New +$9.74M 0.04% 494
2020
Q4
Sell
-539,897
Closed -$5.33M 1505
2020
Q3
$5.33M Buy
+539,897
New +$3.11M 0.04% 429
2019
Q3
Sell
-12,873
Closed -$78K 1185
2019
Q2
$78K Sell
12,873
-5,603
-30% -$39.3K ﹤0.01% 720
2019
Q1
$134K Buy
+18,476
New +$134K ﹤0.01% 905

Other funds holding PACB